PLx Pharma Winddown Corp.
PLXPDelisted May 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001497504
PLx Pharma Winddown Corp. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 16, 2022; 35 institutions reported holding it in 13F filings for Q1 2023, worth $477.6K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding PLx Pharma Winddown Corp. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 40 | −7 |
| Shares | 7.95M | 6.58K | 6.33M | −1.61M (−20.3%) |
| Value | $19.3M | $16.0K | $4.11M | −$15.2M (−78.7%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held PLx Pharma Winddown Corp. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Avantax Planning Partners, Inc. | 10,000 | $7.00K | 0.00% |
| Federated Hermes, Inc. | 743 | $1.00K | 0.00% |
Sold out (9)
Institutions that held PLx Pharma Winddown Corp. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| GW&K Investment Management, LLC | 424,921 | $1.03M |
| D. E. Shaw & Co., Inc. | 64,556 | $157.0K |
| Marshall Wace, LLP | 40,154 | $98.0K |
| Citadel Advisors LLC | 38,998 | $95.0K |
| Bank of America Corp | 29,056 | $71.0K |
| Occudo Quantitative Strategies LP | 29,301 | $71.0K |
| HRT Financial LP | 14,795 | $35.0K |
| Cutler Group LP | 11,424 | $27.0K |
| Captrust Financial Advisors | 550 | $1.00K |
Not filed for Q3 2022 yet (1)
Institutions that held PLx Pharma Winddown Corp. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 6,575 | $16.0K |